New analysis reveals reduction in valproate prescribing
Prescribing of valproate has reduced significantly following the introduction of a quality improvement programme that promotes safety and patient choice. New analysis presented to the National Patient Safety Committee shows: a 53% reduction in initiation in girls aged 0-12 a 60% reduction in 13-54 women started on valproate a 65% reduction in women re-starting valproate […]